18.34

0.05% 0.01

Simulations Plus Inc (SLP)

Overview News Price History Option Chain Financials Why SLP Down? Discussions Forecast Stock Split Dividend History

Simulations Plus Inc stock is traded at $18.34, with a volume of 240.70K. It is up +0.05% in the last 24 hours and up +0.94% over the past month. Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Previous Close:

$18.33

Open:

$18.35

24h Volume:

240.70K

Relative Volume:

0.52

Market Cap:

$370.92M

Revenue:

$80.54M

Net Income/Loss:

$-62.79M

P/E Ratio:

-5.872

EPS:

-3.1233

Net Cash Flow:

$20.76M

1W Performance:

+0.60%

1M Performance:

+0.94%

6M Performance:

-12.00%

1Y Performance:

+39.79%

1-Day Range:

$18.31

$18.38

1-Week Range:

$18.19

$18.38

52-Week Range:

$11.09

$21.01

Simulations Plus Inc Stock (SLP) Company Profile

Name

Simulations Plus Inc

Sector

Healthcare (1071)

Industry

Health Information Services (47)

Phone

661-723-7723

Address

600 PARK OFFICES DRIVE, SUITE 300 #4134, DURHAM, CA

Employee

213

Twitter

@SimulationsPlus

Next Earnings Date

2026-07-13

Latest SEC Filings

SLP's Discussions on Twitter

Compare SLP vs VEEV, BTSG, HQY, TEM, TXG

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SLP Simulations Plus Inc	18.34	370.92M	80.54M	-62.79M	20.76M	-3.1233
VEEV Veeva Systems Inc	186.24	30.25B	3.32B	941.65M	1.64B	5.6161
BTSG Brightspring Health Services Inc	72.91	14.31B	13.65B	169.86M	412.12M	1.0758
HQY Healthequity Inc	94.64	7.91B	1.34B	230.70M	440.96M	2.6695
TEM Tempus Ai Inc	42.69	7.69B	1.36B	-302.91M	-219.93M	-1.7182
TXG 10 X Genomics Inc	46.27	5.87B	638.78M	-22.66M	122.18M	-0.1744

Simulations Plus Inc Stock (SLP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-18-25	Downgrade	BTIG Research	Buy → Neutral
Sep-30-25	Initiated	TD Cowen	Hold
Jul-15-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Nov-15-24	Initiated	Stephens	Overweight
Jul-29-24	Initiated	KeyBanc Capital Markets	Overweight
Jul-16-24	Initiated	JMP Securities	Mkt Perform
Jun-28-24	Initiated	William Blair	Outperform
May-09-23	Initiated	BTIG Research	Buy
Oct-26-21	Upgrade	Craig Hallum	Hold → Buy
Jan-12-21	Downgrade	Craig Hallum	Buy → Hold
Oct-16-20	Initiated	Raymond James	Outperform
Sep-08-20	Initiated	Oppenheimer	Outperform
Jan-06-20	Initiated	Craig Hallum	Buy

View All

Simulations Plus Inc Stock (SLP) Latest News

03:22 AM

Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures - Supply Chain Digital

03:22 AM

Jul 23, 2026

Simulations Plus Sets Shareholder Vote on Cash Merger with Altaris Affiliate - The Globe and Mail

Jul 23, 2026

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG - Finansavisen

Jul 23, 2026

Jul 22, 2026

Simulations Plus (SLP) agrees to $375M cash buyout at 26% premium - Stock Titan

Jul 22, 2026

Jul 21, 2026

Precision Trading with Simulations Plus Inc. (SLP) Risk Zones - Stock Traders Daily

Jul 21, 2026

Simulations Plus (NASDAQ:SLP) Share Price Crosses Above 200-Day Moving AverageTime to Sell? - MarketBeat

Jul 21, 2026

Jul 20, 2026

Simulations Plus (SLP) to go private in $375M all‑cash sale to Altaris - Stock Titan

Jul 20, 2026

Simulations Plus | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo

Jul 20, 2026

Jul 19, 2026

Simulations Plus: The Potential Little Spread Is Not Worth The Risk For New Money, Hold - Seeking Alpha

Jul 19, 2026

Jul 17, 2026

Robbins LLP is Investigating Allegations that the Officers and Di - The National Law Review

Jul 17, 2026

Jul 16, 2026

Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investiga - The National Law Review

Jul 16, 2026

Jul 15, 2026